241:. Upstream processing involves all the steps related to inoculum development, media development, improvement of inoculum by genetic engineering process, optimization of growth kinetics so that product development can improve tremendously. Fermentation has two parts: upstream and downstream. After product development, the next step is the purification of product for desired quality. When they reach the desired density (for batch and fed-batch cultures) they are harvested and moved to the downstream section of the bioprocess.
36:
249:
The downstream part of a bioprocess refers to the part where the cell mass from the upstream are processed to meet purity and quality requirements. Downstream processing is usually divided into three main sections: cell disruption, a purification section and a polishing section. The volatile products
218:
Therapeutic cell manufacturing processes can be separated into upstream processes and downstream processes. The upstream process is defined as the entire process from early cell isolation and cultivation, to cell banking and culture expansion of the cells until final harvest (termination of the
254:
Separation of biomass: separating the biomass (microbial cells) generally carried out by centrifugation or ultra-centrifugation. If the product is biomass, then it is recovered for processing and spent medium is discarded. If the product is extra cellular the biomass will be discarded. Ultra
250:
can be separated by distillation of the harvested culture without pre-treatment. Distillation is done at reduced pressure at continuous stills. At reduced pressure, distillation of product directly from fermentor may be possible. The steps of downstream processing are:
258:
Cell disruption: If the desired product is intra cellular the cell biomass can be disrupted so that the product should be released. The solid-liquid is separated by centrifugation or filtration and cell debris is
265:
Initial purification of metabolites: According to the physico-chemical nature of the product molecule several methods for recovery of product from the clarified fermented broth were used (precipitation,
269:
De-watering: If low amount of product is found in very large volume of spent medium, the volume is reduced by removing water to concentrate the product. It is done by vacuum drying or reverse osmosis.
199:. The goals of cell therapy bioprocessing are to establish reproducible and robust manufacturing processes for the production of therapeutic cells. Commercially relevant bioprocesses will:
222:
Aside from technology challenges, concerning the scalability of culture apparatus, a number of raw material supply risks have emerged in recent years, including the availability of
206:
Supply both clinical and commercial quantities of therapeutic cells throughout the various stages of development. The processes and production technologies must be scalable, and
475:
336:
446:
272:
Polishing of metabolites: this is the final step of making the product 98 to 100% pure. The purified product is mixed with several inert ingredients called
209:
Control the cost of goods (CoGs) of the final drug product. This aspect is critical to building the foundation for a commercially viable industry.
427:
Rowley, J.A. Developing Cell
Therapy Biomanufacturing Processes, Chem Eng Progress, SBE Stem Cell Engineering Nov Supplement, 50-55, 2010.
233:
The upstream part of a bioprocess refers to the first step in which microbes/cells are grown, e.g. bacterial or mammalian cell lines (see
368:
119:
483:
57:
100:
72:
454:
331:
223:
53:
79:
46:
179:, require knowledge of how energy and mass can be transported through materials (momentum, heat transfer, etc.).
436:
Draft
Guidance : Instructions and Template for CMC Reviewers of Human Somatic Cell Therapy IND Applications
86:
510:
326:
306:
196:
164:
321:
286:
168:
155:
Transport of energy and mass is fundamental to many biological and environmental processes. Areas, from
68:
227:
407:
364:
358:
296:
172:
397:
301:
238:
156:
262:
Concentration of broth: The spent medium is concentrated if the product is extracellular.
93:
176:
137:
203:
Produce products that maintain all of the quality standards of biopharmaceutical drugs
504:
311:
291:
192:
17:
234:
188:
149:
35:
402:
385:
276:. The formulated product is packed and sent to the market for the consumers.
273:
411:
141:
160:
187:
Cell therapy bioprocessing is a discipline that bridges the fields of
316:
145:
195:(i.e., biopharmaceutical manufacturing), and is a sub-field of
29:
27:
Process that uses living cells to obtain desired products
386:"The systematic production of cells for cell therapies"
255:
filtration is an alternative to the centrifugation.
60:. Unsourced material may be challenged and removed.
337:Keck Graduate Institute of Applied Life Sciences
219:culture and collection of the live cell batch).
136:is a specific process that uses complete living
8:
401:
120:Learn how and when to remove this message
423:
421:
163:beer) to thermal design of buildings to
384:Kirouac, D. & Zandstra, P. (2008).
349:
7:
58:adding citations to reliable sources
447:"Amgen Bioprocessing Center (ABC)"
25:
360:Advances in Bioprocess Technology
339:(KGI Amgen Bioprocessing Center)
34:
357:Pogaku Ravindra (13 Aug 2015).
45:needs additional citations for
152:) to obtain desired products.
1:
332:Good manufacturing practice
140:or their components (e.g.,
527:
403:10.1016/j.stem.2008.09.001
363:. Springer. p. 424.
245:Downstream bioprocessing
327:Good clinical practice
307:Bioprocess engineering
214:Upstream bioprocessing
197:bioprocess engineering
322:Clinical study design
287:Adverse drug reaction
169:monoclonal antibodies
18:Upstream (bioprocess)
54:improve this article
228:fetal bovine serum
183:Cell bioprocessing
165:biomedical devices
297:Assay sensitivity
173:pollution control
167:, manufacture of
130:
129:
122:
104:
16:(Redirected from
518:
495:
494:
492:
491:
482:. Archived from
472:
466:
465:
463:
462:
453:. Archived from
443:
437:
434:
428:
425:
416:
415:
405:
381:
375:
374:
354:
302:Biomanufacturing
125:
118:
114:
111:
105:
103:
62:
38:
30:
21:
526:
525:
521:
520:
519:
517:
516:
515:
501:
500:
499:
498:
489:
487:
476:"Bioprocessing"
474:
473:
469:
460:
458:
445:
444:
440:
435:
431:
426:
419:
383:
382:
378:
371:
356:
355:
351:
346:
283:
247:
216:
185:
157:food processing
126:
115:
109:
106:
63:
61:
51:
39:
28:
23:
22:
15:
12:
11:
5:
524:
522:
514:
513:
503:
502:
497:
496:
467:
438:
429:
417:
396:(4): 369–381.
390:Cell Stem Cell
376:
369:
348:
347:
345:
342:
341:
340:
334:
329:
324:
319:
314:
309:
304:
299:
294:
289:
282:
279:
278:
277:
270:
267:
263:
260:
256:
246:
243:
215:
212:
211:
210:
207:
204:
184:
181:
177:global warming
128:
127:
42:
40:
33:
26:
24:
14:
13:
10:
9:
6:
4:
3:
2:
523:
512:
511:Biotechnology
509:
508:
506:
486:on 2015-03-23
485:
481:
477:
471:
468:
457:on 2014-07-04
456:
452:
448:
442:
439:
433:
430:
424:
422:
418:
413:
409:
404:
399:
395:
391:
387:
380:
377:
372:
370:9783319179155
366:
362:
361:
353:
350:
343:
338:
335:
333:
330:
328:
325:
323:
320:
318:
315:
313:
312:Biotechnology
310:
308:
305:
303:
300:
298:
295:
293:
292:Adverse event
290:
288:
285:
284:
280:
275:
271:
268:
264:
261:
257:
253:
252:
251:
244:
242:
240:
236:
231:
229:
225:
220:
213:
208:
205:
202:
201:
200:
198:
194:
193:bioprocessing
190:
182:
180:
178:
174:
170:
166:
162:
158:
153:
151:
147:
143:
139:
135:
124:
121:
113:
102:
99:
95:
92:
88:
85:
81:
78:
74:
71: –
70:
66:
65:Find sources:
59:
55:
49:
48:
43:This article
41:
37:
32:
31:
19:
488:. Retrieved
484:the original
479:
470:
459:. Retrieved
455:the original
450:
441:
432:
393:
389:
379:
359:
352:
248:
235:cell culture
232:
221:
217:
189:cell therapy
186:
154:
150:chloroplasts
133:
131:
116:
107:
97:
90:
83:
76:
69:"Bioprocess"
64:
52:Please help
47:verification
44:
480:www.kgi.edu
451:www.kgi.edu
239:bioreactors
159:(including
490:2017-11-17
461:2014-06-28
344:References
274:excipients
259:discarded.
134:bioprocess
110:March 2019
80:newspapers
505:Category
412:18940729
281:See also
142:bacteria
161:brewing
146:enzymes
94:scholar
410:
367:
317:Caco-2
237:), in
226:grade
96:
89:
82:
75:
67:
266:etc.)
138:cells
101:JSTOR
87:books
408:PMID
365:ISBN
191:and
175:and
73:news
398:doi
224:GMP
171:to
56:by
507::
478:.
449:.
420:^
406:.
392:.
388:.
230:.
148:,
144:,
132:A
493:.
464:.
414:.
400::
394:3
373:.
123:)
117:(
112:)
108:(
98:·
91:·
84:·
77:·
50:.
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
